Trainers Directory

I research lipid and lipoprotein metabolism, cholesterol homeostasis, and regulation of adipocyte lipid storage. 

My primary research is studying molecular mechanism of ion channel folding, assembly, degradation, trafficking, and function. I also focus on Ion channel folding diseases, such as genetic epilepsy, and proteostasis of membrane proteins. 

Tingwei Mu 

I focus on basic and translational research in the role of innate immunity in alcoholic liver disease; adipose/liver/gut interactions in liver injury.

Laura Nagy's Biography

I research molecular mechanisms linking inflammation and thrombosis. 

Lalitha Nayak's Biography 

I investigate the interactions of pathogenic mycobacteria with host immune systems. Specifically, I research antibiotic resistance, pathogenesis, cell wall assembly and cell division control in Mycobacterium tuberculosis. 

Liem Nguyen's Biography

Our lab studies platelet signaling and crosstalk with the immune system in thrombosis and cancer. More specifically, we focus on how proteases initiate intracellular signaling through protease activated receptors. We use structural biology, cell signaling, and animal models to uncover molecular mechanisms then verify these in vivo.

Marvin Nieman's Biography 

I research systems biology approaches to interactions of obesity, exercise, and cancer. 

Nora Nock's Biography 

Our lab is interested in understanding how viruses interact with their hosts to cause pathogenesis and disease. Our current work is aimed at elucidating herpesvirus-host interactions, with a particular focus on the human herpesvirus, cytomegalovirus (CMV). We are interested in how CMV usurps cellular processes to maintain long-term latency, drive reactivation given proper cues, and efficiently lytically replicate and spread.

Christine M. O'Connor's Biography 

Research in my lab is focused on understanding T cell differentiation and function within the tumor microenvironment with an emphasis on (1) the differentiation, in-situ localization, and spatial relationships between subsets of CD8 T cells and other immune markers in the tumor microenvironment; (2) the formation and role of tertiary lymphoid structures in antitumor immunity; (3) strategies to improve PD-1 targeted therapy for patients with cancer; and (4) identification of predictive biomarkers to improve patient selection and prognosis for cancer immunotherapy.

Rebecca Obeng's Biography